What role does Cardio Risk Check | Herz-Kreislauf Risiko-Test play in gut health?

The Cardio Risk Check (Herz-Kreislauf Risiko-Test) from MyBody-X is primarily a cardiovascular risk screening tool that analyzes genetic markers such as APOE, FTO, and lipid-related polymorphisms. It is not designed to assess gut health. An indirect link may exist via the inflammation axis: unfavorable cardiovascular gene variants can be associated with systemic inflammatory processes, which in turn may affect the gut barrier and microbiome. However, the evidence for a direct role of the Cardio Risk Check in gut health is weak and largely mechanistic or derived from GWAS. The test results do not provide specific information about gut flora, permeability, or digestive enzymes. For a comprehensive gut health assessment, separate stool or microbiome analyses and clinical parameters (calprotectin, zonulin) are required. The test can serve as a supplementary hint for inflammatory risk but does not replace targeted gut diagnostics. Caution against overinterpretation: single gene variants have small effect sizes and are heavily influenced by environmental and dietary factors.